Genetic Technologies Reported Monday, geneType Identifies 79.5% Of People Tested In U.S., Australia Are At Risk Of Serious Disease
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies Limited (NASDAQ: GENE) reported that their geneType test identified 79.5% of people tested in the U.S. and Australia as being at risk for serious diseases. This finding is expected to drive increased surveillance and early detection efforts.
June 25, 2024 | 10:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genetic Technologies Limited's geneType test identified 79.5% of people tested in the U.S. and Australia as being at risk for serious diseases. This significant finding is likely to drive increased demand for their tests, potentially boosting revenues.
The high percentage of individuals identified at risk by the geneType test is likely to increase demand for Genetic Technologies' products. This could lead to higher revenues as more people seek early detection and intervention.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100